The name 'pancreas' is derived from the Greek 'pan' (all) and 'kreas' (flesh)
Pancreas
Situated in the retroperitoneum
Divided into head (30%), body and tail (70%)
Head lies within the curve of the duodenum, overlying the body of the second lumbar vertebra and the vena cava
Aorta and the superior mesenteric vessels lie behind the neck of the gland
Uncinate process coming off the side of the pancreatic head and passing to the left and behind the superior mesenteric vein
Superior mesenteric vein joins the splenic vein to form the portal vein behind the neck of the pancreas
Tip of the pancreatic tail extends up to the splenic hilum
Pancreas weight
Approximately 80 g
Composition of the pancreas
Exocrine acinar tissue (80–90%)
Endocrine cells (islets of Langerhans)
Exocrine acinar tissue
Organised into lobules
Main pancreatic duct branches into interlobular and intralobular ducts, ductules and, finally, acini
Endocrine cells (islets of Langerhans)
75% are B cells (producing insulin)
20% are A cells (producing glucagon)
Remainder are D cells (producing somatostatin) and a small number of pancreatic polypeptide cells
Capillaries draining the islet cells drain into the portal vein, forming a pancreatic portal system
Approximately 10% of patients will have a significant flow from the main duct through the accessory papilla
Anatomy of the main duodenal papilla (ampulla of Vater)
Outlet of each duct is protected by a complex sphincter mechanism (sphincter of Oddi)
Anomalies of the pancreas
Aplasia
Hypoplasia
Hyperplasia
Hypertrophy
Dysplasia
Variations and anomalies of the ducts
Pancreas divisum
Rotational anomalies
Annular pancreasa
Pancreatic gall bladder
Polycystic disease
Congenital pancreatic cysts
Ectopic pancreatic tissue, accessory pancreasa
Vascular anomalies
Choledochal cysts
Horseshoe pancreas
Cystic fibrosis
Inherited as autosomal recessive condition
Occurs most frequently among Caucasians, in whom it is the most common inherited disorder (incidence of 1:2000 live births in the UK)
Mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene on chromosome 7
CFTR gene creates a cell membrane protein that helps to control the movement of chloride across the cell membrane
Cystic fibrosis
Multisystem disorder of exocrine glands that affects the lungs, intestines, pancreas and liver
Characterised by elevated sodium and chloride ion concentrations in sweat
Organ damage due to blockage of narrow passages by thickened secretions
Chronic pulmonary disease arises from plugging of bronchi and bronchioles
Meconium may set in a sticky mass and produce intestinal obstruction (meconium ileus)
Secretions precipitate in the lumen of the pancreatic duct causing blockage, which results in duct ectasia and fatty replacement of exocrine acinar tissue
Pancreatic exocrine insufficiency leads to fat malabsorption
Steatorrhoea is usually present from birth
Liver may become cirrhotic as a result of bile duct plugging
Infertility is common
Pancreas divisum
Occurs when the embryological ventral and dorsal parts of the pancreas fail to fuse
The dorsal pancreatic duct drains through the accessory papilla
The earliest clinical signs of cystic fibrosis are poor growth, poor appetite, rancid greasy stools, abdominal distension, chronic respiratory disease and finger clubbing
The diagnosis of cystic fibrosis can be made by genetic testing (which may be part of prenatal or newborn screening) or sweat test
Treatment of cystic fibrosis
1. Control of the secondary consequences of the disease
2. Preserve pulmonary function with aggressive physiotherapy and antibiotics
3. Treat malabsorption by administration of oral pancreatic enzyme preparations
4. Diet should be low in fat but contain added salt to replace the high losses in the sweat
Pancreas divisum occurs when the embryological ventral and dorsal parts of the pancreas fail to fuse
The dorsal pancreatic duct drains through the accessory papilla in pancreas divisum
Cystic fibrosis
Absence of the vas deferens in men and thick cervical mucus in women
1. Genetic testing (which may be part of prenatal or newborn screening)
2. Sweat test (Levels of sodium and chloride ions in the sweat above 90 mmol/L confirm the diagnosis)
Treatment of cystic fibrosis
1. Control of the secondary consequences of the disease
2. Preserve pulmonary function with aggressive physiotherapy and antibiotics
3. Treat malabsorption with oral pancreatic enzyme preparations
4. Low fat diet with added salt to replace high losses in sweat
Pancreas divisum
Embryological ventral and dorsal parts of the pancreas fail to fuse, with the dorsal pancreatic duct becoming the main pancreatic duct
Incidence of pancreas divisum ranges from 5% in autopsy series to 10% in some ERCP and MRCP series
Pancreas divisum in asymptomatic people
Does not warrant any intervention
Incidence of pancreas divisum ranges from 25–50% in patients with recurrent acute pancreatitis, chronic pancreatitis and pancreatic pain
Diagnosis of pancreas divisum
MRCP, EUS or ERCP, augmented by injection of secretin if necessary
Treatment of pancreas divisum
1. Endoscopic sphincterotomy and stenting of the minor papilla
2. Surgical intervention (sphincteroplasty, pancreatojejunostomy or resection of the pancreatic head)
Annular pancreas
Failure of complete rotation of the ventral pancreatic bud during development, so that a ring of pancreatic tissue surrounds the second or third part of the duodenum
Annular pancreas is most often seen in association with congenital duodenal stenosis or atresia and is therefore more prevalent in children with Down syndrome
Treatment of annular pancreas
Bypass (duodenoduodenostomy)
Ectopic pancreas
Islands of ectopic pancreatic tissue can be found in various locations in the body
Congenital cystic disease of the pancreas
Sometimes accompanies congenital disease of the kidneys and liver, and occurs as part of the von Hippel–Lindau syndrome
Pancreatic injuries from external trauma
Contusion or laceration of the parenchyma without duct disruption
Major parenchymal destruction with duct disruption (sometimes complete transection)
Rarely, massive destruction of the pancreatic head
Most important factor determining treatment of pancreatic trauma
Whether the pancreatic duct has been disrupted
Presentation of blunt pancreatic trauma
Epigastric pain, rise in serum amylase, CT scan to delineate damage
Management of blunt pancreatic trauma
1. Conservative management if haemodynamically stable, without peritonitis
2. Operation indicated if there is disruption of the main pancreatic duct
Management of penetrating pancreatic trauma
Urgent surgical exploration, distal pancreatectomy if transection in body or tail, haemostasis and drainage for head injury, pancreatoduodenectomy for severe head and duodenal injury
External injury to the pancreas
Other organs are likely to be injured
It is important to ascertain if the pancreatic duct has been disrupted
CT and ERCP are the most useful tests
Surgery is indicated if the main pancreatic duct is disrupted
Iatrogenic injury to the pancreas
Injury to the tail during splenectomy
Injury to the head and accessory duct during Billroth II gastrectomy
Enucleation of islet cell tumours
Duodenal or ampullary bleeding following sphincterotomy
Pancreatic fistula
Follows operative trauma to the gland or complication of pancreatitis, important to define site and epithelial structure it communicates with